nodes	percent_of_prediction	percent_of_DWPC	metapath
Pralatrexate—Methotrexate—systemic scleroderma	0.417	1	CrCtD
Pralatrexate—SLC19A1—Methotrexate—systemic scleroderma	0.111	0.426	CbGbCtD
Pralatrexate—FPGS—Methotrexate—systemic scleroderma	0.0803	0.308	CbGbCtD
Pralatrexate—Raltitrexed—Methotrexate—systemic scleroderma	0.0552	0.2	CrCrCtD
Pralatrexate—Folic Acid—Methotrexate—systemic scleroderma	0.0552	0.2	CrCrCtD
Pralatrexate—Tetrahydrofolic acid—Methotrexate—systemic scleroderma	0.0552	0.2	CrCrCtD
Pralatrexate—Pemetrexed—Methotrexate—systemic scleroderma	0.0552	0.2	CrCrCtD
Pralatrexate—Leucovorin—Methotrexate—systemic scleroderma	0.0552	0.2	CrCrCtD
Pralatrexate—DHFR—Methotrexate—systemic scleroderma	0.0408	0.156	CbGbCtD
Pralatrexate—TYMS—Methotrexate—systemic scleroderma	0.0284	0.109	CbGbCtD
Pralatrexate—Renal failure chronic—Captopril—systemic scleroderma	0.00166	0.0486	CcSEcCtD
Pralatrexate—SLC19A1—digestive system—systemic scleroderma	0.00107	0.0983	CbGeAlD
Pralatrexate—FPGS—connective tissue—systemic scleroderma	0.000986	0.0906	CbGeAlD
Pralatrexate—SLC19A1—lung—systemic scleroderma	0.000893	0.0821	CbGeAlD
Pralatrexate—FPGS—skin of body—systemic scleroderma	0.000891	0.0819	CbGeAlD
Pralatrexate—FPGS—digestive system—systemic scleroderma	0.000712	0.0655	CbGeAlD
Pralatrexate—FPGS—tendon—systemic scleroderma	0.000678	0.0623	CbGeAlD
Pralatrexate—TYMS—connective tissue—systemic scleroderma	0.000647	0.0595	CbGeAlD
Pralatrexate—DHFR—connective tissue—systemic scleroderma	0.00064	0.0589	CbGeAlD
Pralatrexate—FPGS—lung—systemic scleroderma	0.000595	0.0547	CbGeAlD
Pralatrexate—TYMS—smooth muscle tissue—systemic scleroderma	0.000592	0.0544	CbGeAlD
Pralatrexate—TYMS—skin of body—systemic scleroderma	0.000584	0.0537	CbGeAlD
Pralatrexate—Tumour lysis syndrome—Methotrexate—systemic scleroderma	0.000566	0.0166	CcSEcCtD
Pralatrexate—Pharyngolaryngeal pain—Mycophenolic acid—systemic scleroderma	0.00052	0.0153	CcSEcCtD
Pralatrexate—Laryngeal pain—Mycophenolic acid—systemic scleroderma	0.000515	0.0151	CcSEcCtD
Pralatrexate—TYMS—digestive system—systemic scleroderma	0.000467	0.0429	CbGeAlD
Pralatrexate—DHFR—digestive system—systemic scleroderma	0.000463	0.0425	CbGeAlD
Pralatrexate—Neoplasm malignant—Azathioprine—systemic scleroderma	0.000457	0.0134	CcSEcCtD
Pralatrexate—TYMS—tendon—systemic scleroderma	0.000445	0.0409	CbGeAlD
Pralatrexate—DHFR—tendon—systemic scleroderma	0.00044	0.0405	CbGeAlD
Pralatrexate—Neoplasm malignant—Mycophenolic acid—systemic scleroderma	0.000411	0.0121	CcSEcCtD
Pralatrexate—TYMS—lung—systemic scleroderma	0.00039	0.0359	CbGeAlD
Pralatrexate—DHFR—lung—systemic scleroderma	0.000386	0.0355	CbGeAlD
Pralatrexate—Pancytopenia—Pentoxifylline—systemic scleroderma	0.000351	0.0103	CcSEcCtD
Pralatrexate—Sepsis—Leflunomide—systemic scleroderma	0.000319	0.00937	CcSEcCtD
Pralatrexate—Epistaxis—Pentoxifylline—systemic scleroderma	0.000311	0.00912	CcSEcCtD
Pralatrexate—Sepsis—Mycophenolic acid—systemic scleroderma	0.000305	0.00894	CcSEcCtD
Pralatrexate—Upper respiratory tract infection—Mometasone—systemic scleroderma	0.000297	0.0087	CcSEcCtD
Pralatrexate—Epistaxis—Mometasone—systemic scleroderma	0.000268	0.00787	CcSEcCtD
Pralatrexate—Pancytopenia—Captopril—systemic scleroderma	0.000266	0.00781	CcSEcCtD
Pralatrexate—Neutropenia—Captopril—systemic scleroderma	0.000262	0.00769	CcSEcCtD
Pralatrexate—Pain in extremity—Mycophenolic acid—systemic scleroderma	0.000255	0.00748	CcSEcCtD
Pralatrexate—Toxic epidermal necrolysis—Azathioprine—systemic scleroderma	0.000255	0.00747	CcSEcCtD
Pralatrexate—Back pain—Pentoxifylline—systemic scleroderma	0.000249	0.00731	CcSEcCtD
Pralatrexate—Liver function test abnormal—Leflunomide—systemic scleroderma	0.000247	0.00724	CcSEcCtD
Pralatrexate—Hypokalaemia—Leflunomide—systemic scleroderma	0.000243	0.00713	CcSEcCtD
Pralatrexate—Toxic epidermal necrolysis—Leflunomide—systemic scleroderma	0.000241	0.00706	CcSEcCtD
Pralatrexate—Sepsis—Mycophenolate mofetil—systemic scleroderma	0.000241	0.00705	CcSEcCtD
Pralatrexate—Anaemia—Pentoxifylline—systemic scleroderma	0.000238	0.00698	CcSEcCtD
Pralatrexate—Dehydration—Mycophenolic acid—systemic scleroderma	0.000237	0.00695	CcSEcCtD
Pralatrexate—Liver function test abnormal—Mycophenolic acid—systemic scleroderma	0.000235	0.0069	CcSEcCtD
Pralatrexate—Pancytopenia—Azathioprine—systemic scleroderma	0.000232	0.00681	CcSEcCtD
Pralatrexate—Hypokalaemia—Mycophenolic acid—systemic scleroderma	0.000232	0.0068	CcSEcCtD
Pralatrexate—Leukopenia—Pentoxifylline—systemic scleroderma	0.000231	0.00676	CcSEcCtD
Pralatrexate—Pain in extremity—Lisinopril—systemic scleroderma	0.00023	0.00673	CcSEcCtD
Pralatrexate—Pancytopenia—Leflunomide—systemic scleroderma	0.000219	0.00643	CcSEcCtD
Pralatrexate—Neutropenia—Leflunomide—systemic scleroderma	0.000216	0.00633	CcSEcCtD
Pralatrexate—Back pain—Mometasone—systemic scleroderma	0.000215	0.00631	CcSEcCtD
Pralatrexate—Upper respiratory tract infection—Leflunomide—systemic scleroderma	0.000215	0.0063	CcSEcCtD
Pralatrexate—Dehydration—Lisinopril—systemic scleroderma	0.000214	0.00626	CcSEcCtD
Pralatrexate—Oedema—Pentoxifylline—systemic scleroderma	0.00021	0.00617	CcSEcCtD
Pralatrexate—Pancytopenia—Mycophenolic acid—systemic scleroderma	0.000209	0.00614	CcSEcCtD
Pralatrexate—Toxic epidermal necrolysis—Lisinopril—systemic scleroderma	0.000207	0.00606	CcSEcCtD
Pralatrexate—Neutropenia—Mycophenolic acid—systemic scleroderma	0.000206	0.00604	CcSEcCtD
Pralatrexate—Thrombocytopenia—Pentoxifylline—systemic scleroderma	0.000206	0.00604	CcSEcCtD
Pralatrexate—Tachycardia—Pentoxifylline—systemic scleroderma	0.000205	0.00602	CcSEcCtD
Pralatrexate—Upper respiratory tract infection—Mycophenolic acid—systemic scleroderma	0.000205	0.00601	CcSEcCtD
Pralatrexate—Anorexia—Pentoxifylline—systemic scleroderma	0.0002	0.00588	CcSEcCtD
Pralatrexate—Epistaxis—Leflunomide—systemic scleroderma	0.000194	0.0057	CcSEcCtD
Pralatrexate—Cough—Mometasone—systemic scleroderma	0.000194	0.00569	CcSEcCtD
Pralatrexate—Pancytopenia—Lisinopril—systemic scleroderma	0.000188	0.00553	CcSEcCtD
Pralatrexate—Dyspnoea—Pentoxifylline—systemic scleroderma	0.000187	0.0055	CcSEcCtD
Pralatrexate—Dehydration—Mycophenolate mofetil—systemic scleroderma	0.000187	0.00549	CcSEcCtD
Pralatrexate—Liver function test abnormal—Mycophenolate mofetil—systemic scleroderma	0.000186	0.00545	CcSEcCtD
Pralatrexate—Neutropenia—Lisinopril—systemic scleroderma	0.000186	0.00544	CcSEcCtD
Pralatrexate—Epistaxis—Mycophenolic acid—systemic scleroderma	0.000185	0.00543	CcSEcCtD
Pralatrexate—Upper respiratory tract infection—Lisinopril—systemic scleroderma	0.000184	0.00541	CcSEcCtD
Pralatrexate—Hypokalaemia—Mycophenolate mofetil—systemic scleroderma	0.000183	0.00537	CcSEcCtD
Pralatrexate—Decreased appetite—Pentoxifylline—systemic scleroderma	0.000183	0.00536	CcSEcCtD
Pralatrexate—Anaemia—Captopril—systemic scleroderma	0.00018	0.00529	CcSEcCtD
Pralatrexate—Constipation—Pentoxifylline—systemic scleroderma	0.00018	0.00527	CcSEcCtD
Pralatrexate—Anorexia—Mometasone—systemic scleroderma	0.000173	0.00507	CcSEcCtD
Pralatrexate—Gastrointestinal pain—Pentoxifylline—systemic scleroderma	0.000172	0.00504	CcSEcCtD
Pralatrexate—Cough—Captopril—systemic scleroderma	0.00017	0.005	CcSEcCtD
Pralatrexate—Epistaxis—Lisinopril—systemic scleroderma	0.000167	0.00489	CcSEcCtD
Pralatrexate—Abdominal pain—Pentoxifylline—systemic scleroderma	0.000166	0.00488	CcSEcCtD
Pralatrexate—Body temperature increased—Pentoxifylline—systemic scleroderma	0.000166	0.00488	CcSEcCtD
Pralatrexate—Pancytopenia—Mycophenolate mofetil—systemic scleroderma	0.000165	0.00484	CcSEcCtD
Pralatrexate—Sepsis—Prednisone—systemic scleroderma	0.000163	0.00478	CcSEcCtD
Pralatrexate—Neutropenia—Mycophenolate mofetil—systemic scleroderma	0.000163	0.00477	CcSEcCtD
Pralatrexate—Dyspnoea—Mometasone—systemic scleroderma	0.000162	0.00474	CcSEcCtD
Pralatrexate—Decreased appetite—Mometasone—systemic scleroderma	0.000158	0.00463	CcSEcCtD
Pralatrexate—Anaemia—Azathioprine—systemic scleroderma	0.000158	0.00462	CcSEcCtD
Pralatrexate—Fatigue—Mometasone—systemic scleroderma	0.000156	0.00459	CcSEcCtD
Pralatrexate—Thrombocytopenia—Captopril—systemic scleroderma	0.000156	0.00458	CcSEcCtD
Pralatrexate—Back pain—Leflunomide—systemic scleroderma	0.000156	0.00457	CcSEcCtD
Pralatrexate—Tachycardia—Captopril—systemic scleroderma	0.000156	0.00456	CcSEcCtD
Pralatrexate—Leukopenia—Azathioprine—systemic scleroderma	0.000153	0.00447	CcSEcCtD
Pralatrexate—Anorexia—Captopril—systemic scleroderma	0.000152	0.00446	CcSEcCtD
Pralatrexate—Asthenia—Pentoxifylline—systemic scleroderma	0.000151	0.00442	CcSEcCtD
Pralatrexate—Pruritus—Pentoxifylline—systemic scleroderma	0.000149	0.00436	CcSEcCtD
Pralatrexate—Anaemia—Leflunomide—systemic scleroderma	0.000149	0.00436	CcSEcCtD
Pralatrexate—Back pain—Mycophenolic acid—systemic scleroderma	0.000149	0.00436	CcSEcCtD
Pralatrexate—Gastrointestinal pain—Mometasone—systemic scleroderma	0.000148	0.00435	CcSEcCtD
Pralatrexate—Epistaxis—Mycophenolate mofetil—systemic scleroderma	0.000146	0.00429	CcSEcCtD
Pralatrexate—Leukopenia—Leflunomide—systemic scleroderma	0.000144	0.00422	CcSEcCtD
Pralatrexate—Diarrhoea—Pentoxifylline—systemic scleroderma	0.000144	0.00422	CcSEcCtD
Pralatrexate—Abdominal pain—Mometasone—systemic scleroderma	0.000143	0.00421	CcSEcCtD
Pralatrexate—Body temperature increased—Mometasone—systemic scleroderma	0.000143	0.00421	CcSEcCtD
Pralatrexate—Dyspnoea—Captopril—systemic scleroderma	0.000142	0.00417	CcSEcCtD
Pralatrexate—Anaemia—Mycophenolic acid—systemic scleroderma	0.000142	0.00416	CcSEcCtD
Pralatrexate—Cough—Leflunomide—systemic scleroderma	0.00014	0.00412	CcSEcCtD
Pralatrexate—Decreased appetite—Captopril—systemic scleroderma	0.000139	0.00406	CcSEcCtD
Pralatrexate—TYMS—Clobetasol propionate—Mometasone—systemic scleroderma	0.000137	0.117	CbGdCrCtD
Pralatrexate—Leukopenia—Mycophenolic acid—systemic scleroderma	0.000137	0.00403	CcSEcCtD
Pralatrexate—Fatigue—Captopril—systemic scleroderma	0.000137	0.00403	CcSEcCtD
Pralatrexate—Constipation—Captopril—systemic scleroderma	0.000136	0.004	CcSEcCtD
Pralatrexate—Sepsis—Methotrexate—systemic scleroderma	0.000136	0.004	CcSEcCtD
Pralatrexate—Thrombocytopenia—Azathioprine—systemic scleroderma	0.000136	0.00399	CcSEcCtD
Pralatrexate—TYMS—Flunisolide—Mometasone—systemic scleroderma	0.000136	0.115	CbGdCrCtD
Pralatrexate—TYMS—Triamcinolone—Mometasone—systemic scleroderma	0.000134	0.114	CbGdCrCtD
Pralatrexate—Cough—Mycophenolic acid—systemic scleroderma	0.000134	0.00393	CcSEcCtD
Pralatrexate—Back pain—Lisinopril—systemic scleroderma	0.000134	0.00392	CcSEcCtD
Pralatrexate—Vomiting—Pentoxifylline—systemic scleroderma	0.000134	0.00392	CcSEcCtD
Pralatrexate—Rash—Pentoxifylline—systemic scleroderma	0.000133	0.00389	CcSEcCtD
Pralatrexate—Dermatitis—Pentoxifylline—systemic scleroderma	0.000132	0.00388	CcSEcCtD
Pralatrexate—TYMS—Fluticasone Propionate—Mometasone—systemic scleroderma	0.000131	0.111	CbGdCrCtD
Pralatrexate—Gastrointestinal pain—Captopril—systemic scleroderma	0.00013	0.00382	CcSEcCtD
Pralatrexate—Asthenia—Mometasone—systemic scleroderma	0.00013	0.00382	CcSEcCtD
Pralatrexate—Thrombocytopenia—Leflunomide—systemic scleroderma	0.000129	0.00377	CcSEcCtD
Pralatrexate—Pruritus—Mometasone—systemic scleroderma	0.000128	0.00376	CcSEcCtD
Pralatrexate—Tachycardia—Leflunomide—systemic scleroderma	0.000128	0.00376	CcSEcCtD
Pralatrexate—Anaemia—Lisinopril—systemic scleroderma	0.000128	0.00375	CcSEcCtD
Pralatrexate—Body temperature increased—Captopril—systemic scleroderma	0.000126	0.00369	CcSEcCtD
Pralatrexate—Abdominal pain—Captopril—systemic scleroderma	0.000126	0.00369	CcSEcCtD
Pralatrexate—Oedema—Mycophenolic acid—systemic scleroderma	0.000125	0.00367	CcSEcCtD
Pralatrexate—Anorexia—Leflunomide—systemic scleroderma	0.000125	0.00367	CcSEcCtD
Pralatrexate—Nausea—Pentoxifylline—systemic scleroderma	0.000125	0.00366	CcSEcCtD
Pralatrexate—Diarrhoea—Mometasone—systemic scleroderma	0.000124	0.00364	CcSEcCtD
Pralatrexate—Hypokalaemia—Prednisone—systemic scleroderma	0.000124	0.00364	CcSEcCtD
Pralatrexate—TYMS—Diflorasone—Mometasone—systemic scleroderma	0.000124	0.105	CbGdCrCtD
Pralatrexate—Leukopenia—Lisinopril—systemic scleroderma	0.000124	0.00363	CcSEcCtD
Pralatrexate—Thrombocytopenia—Mycophenolic acid—systemic scleroderma	0.000123	0.0036	CcSEcCtD
Pralatrexate—Tachycardia—Mycophenolic acid—systemic scleroderma	0.000122	0.00359	CcSEcCtD
Pralatrexate—Cough—Lisinopril—systemic scleroderma	0.000121	0.00354	CcSEcCtD
Pralatrexate—Anorexia—Mycophenolic acid—systemic scleroderma	0.000119	0.0035	CcSEcCtD
Pralatrexate—Back pain—Mycophenolate mofetil—systemic scleroderma	0.000117	0.00344	CcSEcCtD
Pralatrexate—Dyspnoea—Leflunomide—systemic scleroderma	0.000117	0.00343	CcSEcCtD
Pralatrexate—Vomiting—Mometasone—systemic scleroderma	0.000115	0.00338	CcSEcCtD
Pralatrexate—Rash—Mometasone—systemic scleroderma	0.000114	0.00336	CcSEcCtD
Pralatrexate—Asthenia—Captopril—systemic scleroderma	0.000114	0.00335	CcSEcCtD
Pralatrexate—Dermatitis—Mometasone—systemic scleroderma	0.000114	0.00335	CcSEcCtD
Pralatrexate—Decreased appetite—Leflunomide—systemic scleroderma	0.000114	0.00335	CcSEcCtD
Pralatrexate—Gastrointestinal pain—Azathioprine—systemic scleroderma	0.000114	0.00334	CcSEcCtD
Pralatrexate—Fatigue—Leflunomide—systemic scleroderma	0.000113	0.00332	CcSEcCtD
Pralatrexate—Oedema—Lisinopril—systemic scleroderma	0.000113	0.00331	CcSEcCtD
Pralatrexate—Pruritus—Captopril—systemic scleroderma	0.000113	0.00331	CcSEcCtD
Pralatrexate—Constipation—Leflunomide—systemic scleroderma	0.000112	0.00329	CcSEcCtD
Pralatrexate—Anaemia—Mycophenolate mofetil—systemic scleroderma	0.000112	0.00328	CcSEcCtD
Pralatrexate—Dyspnoea—Mycophenolic acid—systemic scleroderma	0.000112	0.00328	CcSEcCtD
Pralatrexate—Thrombocytopenia—Lisinopril—systemic scleroderma	0.00011	0.00324	CcSEcCtD
Pralatrexate—Neutropenia—Prednisone—systemic scleroderma	0.00011	0.00323	CcSEcCtD
Pralatrexate—Tachycardia—Lisinopril—systemic scleroderma	0.00011	0.00323	CcSEcCtD
Pralatrexate—Abdominal pain—Azathioprine—systemic scleroderma	0.00011	0.00322	CcSEcCtD
Pralatrexate—Body temperature increased—Azathioprine—systemic scleroderma	0.00011	0.00322	CcSEcCtD
Pralatrexate—Diarrhoea—Captopril—systemic scleroderma	0.000109	0.0032	CcSEcCtD
Pralatrexate—Decreased appetite—Mycophenolic acid—systemic scleroderma	0.000109	0.00319	CcSEcCtD
Pralatrexate—TYMS—Budesonide—Mometasone—systemic scleroderma	0.000109	0.0922	CbGdCrCtD
Pralatrexate—Leukopenia—Mycophenolate mofetil—systemic scleroderma	0.000108	0.00318	CcSEcCtD
Pralatrexate—Fatigue—Mycophenolic acid—systemic scleroderma	0.000108	0.00317	CcSEcCtD
Pralatrexate—Nausea—Mometasone—systemic scleroderma	0.000108	0.00316	CcSEcCtD
Pralatrexate—Anorexia—Lisinopril—systemic scleroderma	0.000108	0.00316	CcSEcCtD
Pralatrexate—Gastrointestinal pain—Leflunomide—systemic scleroderma	0.000107	0.00315	CcSEcCtD
Pralatrexate—Constipation—Mycophenolic acid—systemic scleroderma	0.000107	0.00314	CcSEcCtD
Pralatrexate—Cough—Mycophenolate mofetil—systemic scleroderma	0.000106	0.0031	CcSEcCtD
Pralatrexate—Liver function test abnormal—Methotrexate—systemic scleroderma	0.000105	0.00309	CcSEcCtD
Pralatrexate—Abdominal pain—Leflunomide—systemic scleroderma	0.000104	0.00305	CcSEcCtD
Pralatrexate—Body temperature increased—Leflunomide—systemic scleroderma	0.000104	0.00305	CcSEcCtD
Pralatrexate—Toxic epidermal necrolysis—Methotrexate—systemic scleroderma	0.000103	0.00301	CcSEcCtD
Pralatrexate—Gastrointestinal pain—Mycophenolic acid—systemic scleroderma	0.000102	0.003	CcSEcCtD
Pralatrexate—Vomiting—Captopril—systemic scleroderma	0.000101	0.00297	CcSEcCtD
Pralatrexate—Dyspnoea—Lisinopril—systemic scleroderma	0.000101	0.00295	CcSEcCtD
Pralatrexate—Rash—Captopril—systemic scleroderma	0.0001	0.00295	CcSEcCtD
Pralatrexate—Dermatitis—Captopril—systemic scleroderma	0.0001	0.00294	CcSEcCtD
Pralatrexate—Body temperature increased—Mycophenolic acid—systemic scleroderma	9.9e-05	0.0029	CcSEcCtD
Pralatrexate—Abdominal pain—Mycophenolic acid—systemic scleroderma	9.9e-05	0.0029	CcSEcCtD
Pralatrexate—Oedema—Mycophenolate mofetil—systemic scleroderma	9.89e-05	0.0029	CcSEcCtD
Pralatrexate—Decreased appetite—Lisinopril—systemic scleroderma	9.81e-05	0.00288	CcSEcCtD
Pralatrexate—Fatigue—Lisinopril—systemic scleroderma	9.73e-05	0.00285	CcSEcCtD
Pralatrexate—Thrombocytopenia—Mycophenolate mofetil—systemic scleroderma	9.68e-05	0.00284	CcSEcCtD
Pralatrexate—Constipation—Lisinopril—systemic scleroderma	9.65e-05	0.00283	CcSEcCtD
Pralatrexate—Tachycardia—Mycophenolate mofetil—systemic scleroderma	9.65e-05	0.00283	CcSEcCtD
Pralatrexate—Diarrhoea—Azathioprine—systemic scleroderma	9.52e-05	0.00279	CcSEcCtD
Pralatrexate—Nausea—Captopril—systemic scleroderma	9.47e-05	0.00278	CcSEcCtD
Pralatrexate—Anorexia—Mycophenolate mofetil—systemic scleroderma	9.43e-05	0.00276	CcSEcCtD
Pralatrexate—Asthenia—Leflunomide—systemic scleroderma	9.42e-05	0.00276	CcSEcCtD
Pralatrexate—Pancytopenia—Methotrexate—systemic scleroderma	9.35e-05	0.00274	CcSEcCtD
Pralatrexate—Pruritus—Leflunomide—systemic scleroderma	9.29e-05	0.00273	CcSEcCtD
Pralatrexate—Gastrointestinal pain—Lisinopril—systemic scleroderma	9.23e-05	0.00271	CcSEcCtD
Pralatrexate—Neutropenia—Methotrexate—systemic scleroderma	9.21e-05	0.0027	CcSEcCtD
Pralatrexate—Upper respiratory tract infection—Methotrexate—systemic scleroderma	9.15e-05	0.00269	CcSEcCtD
Pralatrexate—Asthenia—Mycophenolic acid—systemic scleroderma	8.99e-05	0.00264	CcSEcCtD
Pralatrexate—Diarrhoea—Leflunomide—systemic scleroderma	8.99e-05	0.00264	CcSEcCtD
Pralatrexate—Abdominal pain—Lisinopril—systemic scleroderma	8.92e-05	0.00262	CcSEcCtD
Pralatrexate—Body temperature increased—Lisinopril—systemic scleroderma	8.92e-05	0.00262	CcSEcCtD
Pralatrexate—Pruritus—Mycophenolic acid—systemic scleroderma	8.86e-05	0.0026	CcSEcCtD
Pralatrexate—Vomiting—Azathioprine—systemic scleroderma	8.84e-05	0.00259	CcSEcCtD
Pralatrexate—Dyspnoea—Mycophenolate mofetil—systemic scleroderma	8.82e-05	0.00259	CcSEcCtD
Pralatrexate—Rash—Azathioprine—systemic scleroderma	8.77e-05	0.00257	CcSEcCtD
Pralatrexate—Dermatitis—Azathioprine—systemic scleroderma	8.76e-05	0.00257	CcSEcCtD
Pralatrexate—Decreased appetite—Mycophenolate mofetil—systemic scleroderma	8.6e-05	0.00252	CcSEcCtD
Pralatrexate—Diarrhoea—Mycophenolic acid—systemic scleroderma	8.57e-05	0.00251	CcSEcCtD
Pralatrexate—Constipation—Mycophenolate mofetil—systemic scleroderma	8.46e-05	0.00248	CcSEcCtD
Pralatrexate—Vomiting—Leflunomide—systemic scleroderma	8.35e-05	0.00245	CcSEcCtD
Pralatrexate—Epistaxis—Methotrexate—systemic scleroderma	8.28e-05	0.00243	CcSEcCtD
Pralatrexate—Rash—Leflunomide—systemic scleroderma	8.28e-05	0.00243	CcSEcCtD
Pralatrexate—Dermatitis—Leflunomide—systemic scleroderma	8.27e-05	0.00243	CcSEcCtD
Pralatrexate—Nausea—Azathioprine—systemic scleroderma	8.26e-05	0.00242	CcSEcCtD
Pralatrexate—Asthenia—Lisinopril—systemic scleroderma	8.1e-05	0.00237	CcSEcCtD
Pralatrexate—Gastrointestinal pain—Mycophenolate mofetil—systemic scleroderma	8.09e-05	0.00237	CcSEcCtD
Pralatrexate—Pruritus—Lisinopril—systemic scleroderma	7.98e-05	0.00234	CcSEcCtD
Pralatrexate—Vomiting—Mycophenolic acid—systemic scleroderma	7.97e-05	0.00234	CcSEcCtD
Pralatrexate—Rash—Mycophenolic acid—systemic scleroderma	7.9e-05	0.00232	CcSEcCtD
Pralatrexate—Dermatitis—Mycophenolic acid—systemic scleroderma	7.89e-05	0.00231	CcSEcCtD
Pralatrexate—Abdominal pain—Mycophenolate mofetil—systemic scleroderma	7.82e-05	0.00229	CcSEcCtD
Pralatrexate—Body temperature increased—Mycophenolate mofetil—systemic scleroderma	7.82e-05	0.00229	CcSEcCtD
Pralatrexate—Nausea—Leflunomide—systemic scleroderma	7.8e-05	0.00229	CcSEcCtD
Pralatrexate—Diarrhoea—Lisinopril—systemic scleroderma	7.72e-05	0.00226	CcSEcCtD
Pralatrexate—Anaemia—Prednisone—systemic scleroderma	7.59e-05	0.00223	CcSEcCtD
Pralatrexate—TYMS—Clobetasol propionate—Prednisone—systemic scleroderma	7.49e-05	0.0637	CbGdCrCtD
Pralatrexate—Nausea—Mycophenolic acid—systemic scleroderma	7.44e-05	0.00218	CcSEcCtD
Pralatrexate—TYMS—Flunisolide—Prednisone—systemic scleroderma	7.4e-05	0.0629	CbGdCrCtD
Pralatrexate—TYMS—Triamcinolone—Prednisone—systemic scleroderma	7.32e-05	0.0622	CbGdCrCtD
Pralatrexate—Vomiting—Lisinopril—systemic scleroderma	7.18e-05	0.0021	CcSEcCtD
Pralatrexate—Rash—Lisinopril—systemic scleroderma	7.12e-05	0.00209	CcSEcCtD
Pralatrexate—Dermatitis—Lisinopril—systemic scleroderma	7.11e-05	0.00209	CcSEcCtD
Pralatrexate—Asthenia—Mycophenolate mofetil—systemic scleroderma	7.09e-05	0.00208	CcSEcCtD
Pralatrexate—Pruritus—Mycophenolate mofetil—systemic scleroderma	7e-05	0.00205	CcSEcCtD
Pralatrexate—Diarrhoea—Mycophenolate mofetil—systemic scleroderma	6.77e-05	0.00198	CcSEcCtD
Pralatrexate—TYMS—Diflorasone—Prednisone—systemic scleroderma	6.75e-05	0.0574	CbGdCrCtD
Pralatrexate—Nausea—Lisinopril—systemic scleroderma	6.7e-05	0.00197	CcSEcCtD
Pralatrexate—Oedema—Prednisone—systemic scleroderma	6.7e-05	0.00197	CcSEcCtD
Pralatrexate—Back pain—Methotrexate—systemic scleroderma	6.64e-05	0.00195	CcSEcCtD
Pralatrexate—Tachycardia—Prednisone—systemic scleroderma	6.54e-05	0.00192	CcSEcCtD
Pralatrexate—Anorexia—Prednisone—systemic scleroderma	6.39e-05	0.00187	CcSEcCtD
Pralatrexate—Anaemia—Methotrexate—systemic scleroderma	6.34e-05	0.00186	CcSEcCtD
Pralatrexate—Vomiting—Mycophenolate mofetil—systemic scleroderma	6.29e-05	0.00184	CcSEcCtD
Pralatrexate—Rash—Mycophenolate mofetil—systemic scleroderma	6.23e-05	0.00183	CcSEcCtD
Pralatrexate—Dermatitis—Mycophenolate mofetil—systemic scleroderma	6.23e-05	0.00183	CcSEcCtD
Pralatrexate—Leukopenia—Methotrexate—systemic scleroderma	6.14e-05	0.0018	CcSEcCtD
Pralatrexate—Cough—Methotrexate—systemic scleroderma	5.99e-05	0.00176	CcSEcCtD
Pralatrexate—TYMS—Budesonide—Prednisone—systemic scleroderma	5.92e-05	0.0503	CbGdCrCtD
Pralatrexate—Nausea—Mycophenolate mofetil—systemic scleroderma	5.87e-05	0.00172	CcSEcCtD
Pralatrexate—Decreased appetite—Prednisone—systemic scleroderma	5.83e-05	0.00171	CcSEcCtD
Pralatrexate—Fatigue—Prednisone—systemic scleroderma	5.78e-05	0.00169	CcSEcCtD
Pralatrexate—Constipation—Prednisone—systemic scleroderma	5.73e-05	0.00168	CcSEcCtD
Pralatrexate—TYMS—Danazol—Prednisone—systemic scleroderma	5.67e-05	0.0482	CbGdCrCtD
Pralatrexate—Thrombocytopenia—Methotrexate—systemic scleroderma	5.48e-05	0.00161	CcSEcCtD
Pralatrexate—Gastrointestinal pain—Prednisone—systemic scleroderma	5.48e-05	0.00161	CcSEcCtD
Pralatrexate—Anorexia—Methotrexate—systemic scleroderma	5.34e-05	0.00157	CcSEcCtD
Pralatrexate—Abdominal pain—Prednisone—systemic scleroderma	5.3e-05	0.00155	CcSEcCtD
Pralatrexate—Body temperature increased—Prednisone—systemic scleroderma	5.3e-05	0.00155	CcSEcCtD
Pralatrexate—Dyspnoea—Methotrexate—systemic scleroderma	4.99e-05	0.00146	CcSEcCtD
Pralatrexate—Decreased appetite—Methotrexate—systemic scleroderma	4.87e-05	0.00143	CcSEcCtD
Pralatrexate—Fatigue—Methotrexate—systemic scleroderma	4.83e-05	0.00142	CcSEcCtD
Pralatrexate—Asthenia—Prednisone—systemic scleroderma	4.81e-05	0.00141	CcSEcCtD
Pralatrexate—Pruritus—Prednisone—systemic scleroderma	4.74e-05	0.00139	CcSEcCtD
Pralatrexate—Diarrhoea—Prednisone—systemic scleroderma	4.59e-05	0.00134	CcSEcCtD
Pralatrexate—Gastrointestinal pain—Methotrexate—systemic scleroderma	4.58e-05	0.00134	CcSEcCtD
Pralatrexate—Abdominal pain—Methotrexate—systemic scleroderma	4.43e-05	0.0013	CcSEcCtD
Pralatrexate—Body temperature increased—Methotrexate—systemic scleroderma	4.43e-05	0.0013	CcSEcCtD
Pralatrexate—Vomiting—Prednisone—systemic scleroderma	4.26e-05	0.00125	CcSEcCtD
Pralatrexate—Rash—Prednisone—systemic scleroderma	4.23e-05	0.00124	CcSEcCtD
Pralatrexate—Dermatitis—Prednisone—systemic scleroderma	4.22e-05	0.00124	CcSEcCtD
Pralatrexate—Asthenia—Methotrexate—systemic scleroderma	4.02e-05	0.00118	CcSEcCtD
Pralatrexate—Nausea—Prednisone—systemic scleroderma	3.98e-05	0.00117	CcSEcCtD
Pralatrexate—Pruritus—Methotrexate—systemic scleroderma	3.96e-05	0.00116	CcSEcCtD
Pralatrexate—Diarrhoea—Methotrexate—systemic scleroderma	3.83e-05	0.00112	CcSEcCtD
Pralatrexate—Vomiting—Methotrexate—systemic scleroderma	3.56e-05	0.00104	CcSEcCtD
Pralatrexate—Rash—Methotrexate—systemic scleroderma	3.53e-05	0.00104	CcSEcCtD
Pralatrexate—Dermatitis—Methotrexate—systemic scleroderma	3.53e-05	0.00103	CcSEcCtD
Pralatrexate—Nausea—Methotrexate—systemic scleroderma	3.33e-05	0.000976	CcSEcCtD
